Clinical trial
N-acetylcysteine in Intra-amniotic Infection/Inflammation
NCT00397735 · Ohio State University, Other · Completed
Key facts
| NCT number | NCT00397735 |
|---|---|
| Title | N-acetylcysteine in Intra-amniotic Infection/Inflammation |
| Official title | Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation |
| Lead sponsor | Ohio State University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Labor, Premature, Preterm Premature Rupture of the Membranes, Infection, Inflammation, Chorioamnionitis |
| Intervention type | Drug, Procedure |
| Interventions | amniocentesis, N-acetylcysteine or placebo |
| Enrollment | 68 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 29, 2012 |
| Completion | Aug 1, 2018 |
| First posted | Nov 9, 2006 |
| Last update posted | Oct 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: